| SRPT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SRPT market cap history going back to 7/12/2012:
Also see: SRPT Shares Outstanding History and SRPT YTD Return |
| SRPT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SRPT Historical Market Cap: +25.10% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SRPT Stock Price Chart |
| About Sarepta Therapeutics Inc |
| Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. We show 55 historical shares outstanding datapoints in our SRPT shares outstanding history coverage, used to compute SRPT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRPT market cap history over the course of time is important for investors interested in comparing SRPT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRPT versus a peer is one thing; comparing SRPT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRPT can fluctuate over the course of history. With this page we aim to empower investors researching SRPT by allowing them to research the SRPT market cap history. |
| SRPT Current Stock Quote |
Quotes delayed 20 minutes  Free SRPT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SRPT Share Performance |
| Market Cap Peers |
| Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SRRA Market Cap History SRRK Market Cap History SRTS Market Cap History SRZN Market Cap History SSII Market Cap History SSKN Market Cap History STAA Market Cap History STAB Market Cap History STE Market Cap History STEX Market Cap History More Healthcare companies » |
SRPT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
